Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...
TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported fourth-quarter earnings of $917.7 million. On a per-share basis, the Tarrytown, New York-based ...
Hosted on MSN14d
Regeneron beats quarterly estimates on eczema drug demand; launches dividend program(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales ... by lower inventory levels and a lower net selling price ...
TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: TD Cowen 45th Annual Health Care Conference at ...
Herricks School District held its first budget meeting of the year last Thursday. The district’s Board of Education estimated ...
Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported fourth-quarter earnings of $917.7 million. On a per-share basis, the Tarrytown, New York-based company said it had profit of $8.06.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback